Bio-Works Technologies AB (publ)

SSE:BIOWKS.ST

4.85 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Revenue 10.91410.91422.06811.03423.17511.58818.1459.07313.6228.048.28820.141.7711.7711.6632.0311.7851.6291.5570.6022.3540.6591.4072.1421.1070.981.8581.8580.593
Cost of Revenue 4.3064.30651.3764.23245.9363.73941.9582.49835.5371.20431.0230.4721.461.46-0.3130.411-0.618-0.0180.6320.189-0.084-0.178-0.0590.5681.544-1.4150.230.23-0.037
Gross Profit 6.6096.609-29.3086.802-22.7617.849-23.8136.575-21.9156.836-22.73519.6680.3110.3111.9761.622.4031.6470.9250.4132.4380.8371.4661.574-0.4372.3951.6291.6290.63
Gross Profit Ratio 0.6060.606-1.3280.616-0.9820.677-1.3120.725-1.6090.85-2.7430.9770.1750.1751.1880.7981.3461.0110.5940.6861.0361.271.0420.735-0.3952.4440.8760.8761.062
Reseach & Development Expenses 000000000.1160.116000.1270.127000.419000000000000
General & Administrative Expenses 000000000000005.1865.92911.5355.5355.4474.1447.1712.9983.5883.2163.6852.402000.936
Selling & Marketing Expenses 00000000000000000000000000000
SG&A 19.50919.50921.30521.30519.09819.09818.37618.37616.38416.38414.86814.86812.25112.2515.1865.92911.5355.5355.4474.1447.1712.9983.5883.2163.6852.4026.526.520.936
Other Expenses 000000000000006.3347.24312.6757.437.0270000000000
Operating Expenses 19.54319.54321.67521.67518.46318.46318.4718.4715.97415.97415.24315.24312.27812.27811.5213.17224.2112.96512.47410.81124.9768.75210.3518.9538.8426.5856.6896.6896.321
Operating Income -13.657-13.657-29.308-15.095-22.761-11.483-23.813-12.089-21.915-10.107-22.7354.628-12.274-12.274-9.544-11.552-21.807-11.318-11.557-10.39-21.773-7.915-8.848-7.333-9.257-4.181-5.444-5.444-5.288
Operating Income Ratio -1.251-1.251-1.328-1.368-0.982-0.991-1.312-1.332-1.609-1.257-2.7430.23-6.932-6.932-5.739-5.688-12.217-6.948-7.423-17.259-9.249-12.011-6.289-3.423-8.362-4.266-2.93-2.93-8.917
Total Other Income Expenses Net 0.6250.6250.6380.761.4010.80.4830.4243.6640.98131.617-0.1870.3290.329-0.2740.251.641-0.079-0.0030.012-0.0010.011-0.0010.059-0.034-0.0350.3690.369-0.444
Income Before Tax -13.032-13.032-28.67-14.335-21.36-10.683-23.33-11.665-18.251-9.1268.8824.441-11.945-11.945-9.818-11.302-20.166-11.397-11.557-10.39-21.774-7.904-8.849-7.333-9.291-4.216-5.075-5.075-5.732
Income Before Tax Ratio -1.194-1.194-1.299-1.299-0.922-0.922-1.286-1.286-1.34-1.1351.0720.221-6.746-6.746-5.904-5.565-11.297-6.996-7.423-17.259-9.25-11.994-6.289-3.423-8.393-4.302-2.731-2.731-9.666
Income Tax Expense 0.990.990.1070.0540.1330.0270.2020.1013.5681.7840.0040.002000.0050.0021.641-0.079-0.0030.01200.01100.05900000
Net Income -14.022-14.022-28.777-14.389-21.494-10.709-23.532-11.766-21.82-10.918.8784.439-11.945-11.945-9.823-11.304-20.166-11.397-11.557-10.39-21.774-7.904-8.849-7.333-9.291-4.216-5.075-5.075-5.732
Net Income Ratio -1.285-1.285-1.304-1.304-0.927-0.924-1.297-1.297-1.602-1.3571.0710.22-6.746-6.746-5.907-5.566-11.297-6.996-7.423-17.259-9.25-11.994-6.289-3.423-8.393-4.302-2.731-2.731-9.666
EPS -0.38-0.38-0.82-0.41-0.61-0.3-0.67-0.34-0.68-0.340.290.15-0.39-0.39-0.32-0.37-0.66-0.38-0.6-0.54-1.13-0.41-0.46-0.38-0.48-0.21-0.49-0.49-0.29
EPS Diluted -0.38-0.38-0.82-0.41-0.61-0.3-0.67-0.34-0.68-0.340.280.15-0.39-0.39-0.32-0.36-0.64-0.38-0.57-0.51-1.09-0.41-0.46-0.37-0.46-0.21-0.49-0.49-0.29
EBITDA -13.503-13.503-29.006-14.944-22.498-11.352-23.601-11.983-21.552-10.034-22.3914.8-12.092-12.092-9.634-11.142-19.421-10.859-11.019-9.857-15.998-7.328-8.263-6.758-8.687-3.626-4.894-4.894-3.792
EBITDA Ratio -1.237-1.237-1.314-1.354-0.971-0.98-1.301-1.321-1.582-1.248-2.7020.238-6.83-6.83-5.793-5.486-10.88-6.666-7.077-16.374-6.796-11.12-5.873-3.155-7.847-3.7-2.634-2.634-6.395